Pay in 4 interest-free payments of $7.16 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
If Phase 3 TRIUMPH trials read out positively and FDA approval comes through on schedule, retatrutide could be on pharmacy shelves in late 2027 or 2028
Retatrutide is a novel triple receptor agonist, meaning it simultaneously activates three distinct hormone receptors involved in the regulation of appetite, blood glucose, and energy balance
Designed for adults with obesity or overweight individuals with weight-related complications, this oral option mimics natural hormones to regulate appetite and reduce cravings
The lyophilized powder in your vial is fragile
US$ 28.93
US$ 26.16
US$ 25.84
US$ 22.77
US$ 22.66
US$ 25.03
US$ 28.71
US$ 23.19
US$ 22.20
